Detalhe da pesquisa
1.
TCF1-LEF1 co-expression identifies a multipotent progenitor cell (TH2-MPP) across human allergic diseases.
Nat Immunol
; 25(5): 902-915, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38589618
2.
Nasal polyp antibody-secreting cells display proliferation signature in aspirin-exacerbated respiratory disease.
J Allergy Clin Immunol
; 153(2): 527-532, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-37898408
3.
Type 2 inflammation drives an airway basal stem cell program through insulin receptor substrate signaling.
J Allergy Clin Immunol
; 151(6): 1536-1549, 2023 06.
Artigo
Inglês
| MEDLINE | ID: mdl-36804595
4.
Reconstituting Spore Cortex Peptidoglycan Biosynthesis Reveals a Deacetylase That Catalyzes Transamidation.
Biochemistry
; 62(8): 1342-1346, 2023 04 18.
Artigo
Inglês
| MEDLINE | ID: mdl-37021938
5.
Co-treatment of non-steroidal anti-inflammatory drug-exacerbated respiratory disease with dupilumab and aspirin therapy after desensitization.
Clin Exp Allergy
; 53(9): 974-977, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37246613
6.
Dupilumab-associated arthralgia in patients with aspirin-exacerbated respiratory disease.
Ann Allergy Asthma Immunol
; 128(4): 469-472, 2022 04.
Artigo
Inglês
| MEDLINE | ID: mdl-35124224
7.
Optimizing cryopreservation of nasal polyp tissue for cellular functional studies and single-cell RNA sequencing.
Int Forum Allergy Rhinol
; 2023 Sep 23.
Artigo
Inglês
| MEDLINE | ID: mdl-37742089
8.
Increased epithelial mTORC1 activity in chronic rhinosinusitis with nasal polyps.
bioRxiv
; 2023 Oct 17.
Artigo
Inglês
| MEDLINE | ID: mdl-37904989
9.
Augmented Reality Microscopy in the Management of Cerebellopontine Lesions and Microvascular Decompression: A Pilot Study.
Otol Neurotol Open
; 1(2): e004, 2021 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-38550356
10.
Quantifying tinnitus suppression in cochlear implantation using tinnitus interval-limited tracking.
Laryngoscope
; 130(8): 2047-2052, 2020 08.
Artigo
Inglês
| MEDLINE | ID: mdl-31800110
11.
Switch patterns in a cohort of individuals with asthma who received omalizumab or mepolizumab therapy.
J Allergy Clin Immunol Pract
; 11(3): 946-948.e1, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36384205